Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal vs Intravenous Ketorolac for Acute Renal Colic
NCT04441762Phase 3Completed
- Sponsor
- Oman Medical Specialty Board
- Start
- Dec 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketorolac in Renal colic (2 arms), sponsored by Oman Medical Specialty Board. Primary endpoint: Visual Analog Scale Pain Score. Started Dec 2020; status: completed.
02
Drugs
ketorolac
03
Conditions
Renal colic
Beyond the preview
Go deeper on NCT04441762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04441762.